Foust Hollie K reported option exercise involving 4,000 derivative units of CONMED Corp at $0.00 for $0 on Nov 4, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
General Counsel & Corp Sec
General Counsel & Corp Sec
Filed Nov 6, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
4,000RSUs (Restricted Stock Units)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Nov 4, 2026Option exercise
Filed
Nov 6, 2026, 3:02 PM ET2-day reporting delay
Accession
0000816956-26-000115Code M · Transaction 394525
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 4, 2026Option exercise4,000$0.00$0Trade 394523
Nov 4, 2026Tax withholding1,124$53.66−$60,313.84Trade 394524
3 transaction rows in this filing. Joint filers share the same rows.

CNMD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CNMD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −8.1%1w ago −8.3%1d ago −8.3%
Returns since7d −1.8%30d90d180d1y

Footnotes in full

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company"). F2: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 50% vesting after year 1 and 50% vesting after year 2.